Yes, sepsis can cause blood clots, and it does so frequently. The intense inflammatory response that defines sepsis directly activates the body’s clotting system, sometimes leading to clots in both small and large blood vessels. In one study of patients with severe sepsis and septic shock, 37% developed blood clots despite receiving standard preventive treatment.
How Sepsis Triggers Clotting
Under normal circumstances, your blood maintains a careful balance between clotting and staying fluid. Sepsis disrupts this balance through a chain reaction that starts with your immune system. When bacteria or other pathogens flood the bloodstream, immune cells detect them and release a surge of inflammatory signaling molecules. These molecules do more than just fight infection. They also switch on the clotting process by activating key clotting proteins in the blood.
At the same time, sepsis damages the inner lining of blood vessels. Healthy blood vessels are coated with a thin, sugar-rich protective layer that keeps blood flowing smoothly and prevents platelets from sticking to vessel walls. During sepsis, this protective layer breaks apart. Once it’s gone, the exposed vessel surface attracts platelets and triggers clot formation directly at the vessel wall. The combination of inflammatory signals activating clotting proteins from the inside and vessel damage promoting clotting from the outside creates a powerful, system-wide push toward clot formation.
The body also loses its ability to break down clots once they form. Normally, a built-in cleanup system dissolves clots after they’ve done their job. In sepsis, the cells lining blood vessels overproduce a substance that blocks this cleanup process, so clots accumulate rather than being cleared away.
Tiny Clots, Major Organ Damage
One of the most dangerous consequences of sepsis-related clotting happens at the microscopic level. Tiny clots, called microthrombi, form inside the smallest blood vessels throughout the body. These capillaries are where oxygen and nutrients pass from the blood into your organs. When microthrombi block these vessels, tissues downstream are starved of oxygen.
This is a key reason sepsis leads to organ failure. The kidneys, lungs, liver, and brain all depend on constant blood flow through their capillary networks. When thousands of microthrombi form simultaneously across multiple organs, the resulting oxygen deprivation can cause widespread tissue injury. This progression from sepsis to clotting to organ failure is known as multiple organ dysfunction syndrome, and it’s one of the leading causes of death in intensive care units.
Disseminated Intravascular Coagulation
The most severe form of sepsis-related clotting is called disseminated intravascular coagulation, or DIC. In DIC, clotting becomes so widespread and uncontrolled that the body burns through its supply of platelets and clotting proteins. This creates a paradox: a patient can have dangerous clots forming throughout their body while simultaneously being at risk of uncontrolled bleeding because the ingredients needed for normal clotting have been used up.
Doctors diagnose DIC using a scoring system based on blood tests. The key markers include a low platelet count (the small cell fragments that help form clots), elevated D-dimer levels (a byproduct that rises when clots are being formed and broken down), prolonged clotting time, and low fibrinogen (the protein that forms the structural framework of a clot). Patients whose scores cross a specific threshold are classified as having overt DIC. The mortality implications are stark: in one study comparing outcomes, the mortality rate for patients progressing toward DIC reached 48%, compared to just 6% for sepsis patients without clotting complications.
Larger Clots: DVT and Pulmonary Embolism
Beyond the microscopic level, sepsis also increases the risk of larger, more familiar types of blood clots. Deep vein thrombosis (DVT), where clots form in the legs or arms, and pulmonary embolism, where clots travel to the lungs, are both significantly more common in sepsis patients. A prospective study published in the journal Chest found that even when every patient received guideline-recommended clot prevention, over 37% of those with severe sepsis or septic shock developed a blood clot. Of those clots, 88% were considered clinically significant. Among patients with central venous catheters (IV lines placed in large veins), nearly one in four developed a clot in the arm where the catheter was placed.
These numbers are striking because they reflect what happens with preventive measures in place. Without prophylaxis, the rates would likely be even higher. The risk factors compound: sepsis patients are typically immobilized in bed, often have catheters in their veins, and have a clotting system that’s already in overdrive from inflammation.
How Clot Risk Is Managed During Sepsis
The Surviving Sepsis Campaign, which sets the international standard for sepsis care, recommends that all sepsis patients receive medication to prevent blood clots unless there’s a specific reason they can’t (such as active bleeding). The preferred approach uses a type of blood thinner given by injection, with low-molecular-weight heparin recommended over older formulations because it’s associated with better outcomes and fewer complications.
For patients who develop DIC, management becomes more complex. Treatment focuses on addressing the underlying infection, since the clotting storm won’t resolve until the sepsis itself is controlled. Patients may need transfusions of platelets or clotting factors to replace what’s been consumed, particularly if they’re bleeding. The goal is to interrupt the cycle where infection drives inflammation, inflammation drives clotting, and clotting drives organ failure.
Clot Risk Doesn’t End at Discharge
The elevated risk of blood clots doesn’t disappear the moment sepsis resolves. The inflammatory state triggered by a severe infection can persist for weeks to months, keeping the clotting system on a heightened alert. Research has shown that the pro-inflammatory changes sepsis causes in the body increase the risk of both arterial clots (which cause heart attacks and strokes) and venous clots (DVT and pulmonary embolism) well beyond the acute illness. This elevated risk extends at least 30 days after the initial event and, based on broader evidence linking inflammation to clotting, may persist even longer.
For sepsis survivors, this means that symptoms like leg swelling, chest pain, sudden shortness of breath, or new neurological changes in the weeks after hospitalization warrant urgent attention. The body’s clotting system can remain tilted toward clot formation even after the infection is gone and the patient feels like they’re recovering.